1249667

John Hudson, M.D. — FEI 3020137046

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 13, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Austin, TX (United States)

Additional Details

Clinical Investigator (CI)